Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 532 of 1,261

  1. US 10131907

    Glycoconjugates of RNA interference agents

    Alnylam Pharmaceuticals, Inc. · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  2. US 10135517

    Relay link HARQ operation

    BlackBerry Limited · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  3. US 10131676

    Compounds, compositions and methods

    DENALI THERAPEUTICS INC. · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  4. US 10131668

    Substituted imidazo[1,5-a]pYRAZINES for modulation of IRE1

    The Regents of the University of California · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  5. US 10130723

    TCO conjugates and methods for delivery of therapeutic agents

    The Regents of the University of California · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  6. US 10131659

    Iodonium analogs as inhibitors of NADPH oxidases and other flavin dehydrogenases; formulations thereof; and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  7. US 10130701

    Coronavirus

    The Pirbright Institute · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  8. US 10130681

    Use of a VEGF antagonist to treat angiogenic eye disorders

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  9. US 10130711

    Chemical structures for localized delivery of therapeutic agents

    The Regents of the University of California · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  10. US 10130696

    Method of conferring a protective immune response to norovirus

    Takeda Vaccines, Inc. · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  11. US 10130677

    Antimicrobial peptide and uses thereof

    ACADEMISCH MEDISCH CENTRUM · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  12. US 10130659

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  13. US 10130658

    Method of ex vivo enhancement of immune cell activity for cancer immunotherapy with a small molecule ablative compound

    Provectus Pharmatech, Inc. · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  14. US 10130671

    Chardonnay grape seed products for nonalcoholic fatty liver disease

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  15. US 10130676

    Therapeutic peptides for cerebrovascular diseases

    Prime Bio-Drug Development Limited · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  16. US 10130623

    Tyrosine kinase inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  17. US 10130621

    Analogs of pridopidine, their preparation and use

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  18. US 10130607

    Methods of reducing blood lactate concentration

    Stokely-Van Camp, Inc. · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  19. US 10130720

    Composition comprising a polymeric reagent

    Nektar Therapeutics · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  20. US 10130604

    Composition and method for treating neurodegenerative disease

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  21. US 10130600

    Lipid scavenging in Ras cancers

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  22. US 10130560

    Bioactive “smart” dental composite materials

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  23. US 10130593

    Methods of regulating cannabinoid receptor activity-related disorders and diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  24. US 10130080

    Obesity animal model and methods for making and using thereof

    PERFECT (CHINA) CO., LTD. · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.